학술논문

Proportion of patients without mental disorders being treated in mental health services worldwide.
Document Type
Academic Journal
Author
Bruffaerts R; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Posada-Villa J; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Al-Hamzawi AO; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Gureje O; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Huang Y; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Hu C; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Bromet EJ; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Viana MC; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Hinkov HR; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Karam EG; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Borges G; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Florescu SE; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Williams DR; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Demyttenaere K; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Kovess-Masfety V; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Matschinger H; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Levinson D; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; de Girolamo G; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Ono Y; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; de Graaf R; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Browne MO; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Bunting B; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Xavier M; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Haro JM; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa; Kessler RC; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
Source
Publisher: Cambridge University Press Country of Publication: England NLM ID: 0342367 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1472-1465 (Electronic) Linking ISSN: 00071250 NLM ISO Abbreviation: Br J Psychiatry Subsets: MEDLINE
Subject
Language
English
Abstract
Background: Previous research suggests that many people receiving mental health treatment do not meet criteria for a mental disorder but are rather 'the worried well'.
Aims: To examine the association of past-year mental health treatment with DSM-IV disorders.
Method: The World Health Organization's World Mental Health (WMH) Surveys interviewed community samples of adults in 23 countries (n = 62 305) about DSM-IV disorders and treatment in the past 12 months for problems with emotions, alcohol or drugs.
Results: Roughly half (52%) of people who received treatment met criteria for a past-year DSM-IV disorder, an additional 18% for a lifetime disorder and an additional 13% for other indicators of need (multiple subthreshold disorders, recent stressors or suicidal behaviours). Dose-response associations were found between number of indicators of need and treatment.
Conclusions: The vast majority of treatment in the WMH countries goes to patients with mental disorders or other problems expected to benefit from treatment.
(Royal College of Psychiatrists.)